throbber
Design and synthesis of a 3ⴕ-O-allyl photocleavable
`fluorescent nucleotide as a reversible terminator
`for DNA sequencing by synthesis
`
`Hameer Ruparel*†, Lanrong Bi*†, Zengmin Li*†, Xiaopeng Bai*†‡, Dae Hyun Kim*§, Nicholas J. Turro†‡, and Jingyue Ju*†¶
`
`*Columbia Genome Center, Columbia University College of Physicians and Surgeons, New York, NY 10032; and Departments of †Chemical Engineering,
`‡Chemistry, and §Biomedical Engineering, Columbia University, New York, NY 10027
`
`Contributed by Nicholas J. Turro, March 10, 2005
`
`DNA sequencing by synthesis (SBS) offers an approach for poten-
`tial high-throughput sequencing applications. In this method, the
`ability of an incoming nucleotide to act as a reversible terminator
`for a DNA polymerase reaction is an important requirement to
`unambiguously determine the identity of the incorporated nucle-
`otide before the next nucleotide is added. A free 3ⴕ-OH group on
`the terminal nucleotide of the primer is necessary for the DNA
`polymerase to incorporate an incoming nucleotide. Therefore, if
`the 3ⴕ-OH group of an incoming nucleotide is capped by a chemical
`moiety, it will cause the polymerase reaction to terminate after the
`nucleotide is incorporated into the DNA strand. If the capping
`group is subsequently removed to generate a free 3ⴕ-OH, the
`polymerase reaction will reinitialize. We report here the design and
`synthesis of a 3ⴕ-modified photocleavable fluorescent nucleotide,
`3ⴕ-O-allyl-dUTP-PC-Bodipy-FL-510 (PC-Bodipy, photocleavable 4,4-
`difluoro-4-bora-3␣,4␣-diaza-s-indacene), as a reversible terminator
`for SBS. This nucleotide analogue contains an allyl moiety capping
`the 3ⴕ-OH group and a fluorophore Bodipy-FL-510 linked to the 5
`position of the uracil through a photocleavable 2-nitrobenzyl
`linker. Here, we have shown that this nucleotide is a good sub-
`strate for a DNA polymerase. After the nucleotide was successfully
`incorporated into a growing DNA strand and the fluorophore was
`photocleaved, the allyl group was removed by using a Pd-catalyzed
`reaction to reinitiate the polymerase reaction, thereby establishing
`the feasibility of using such nucleotide analogues as reversible
`terminators for SBS.
`
`2-nitrobenzyl linker 兩 photocleavage
`
`The completion of the Human Genome Project (1, 2) has led
`
`to an increased demand for high-throughput and rapid DNA
`sequencing methods to identify genetic variants for applications
`in pharmacogenomics (3), disease gene discovery (4, 5), and
`gene function studies (6). Current state-of-the-art DNA se-
`quencing technologies (7–11) to some extent address the accu-
`racy and throughput requirements but suffer limitations with
`respect to cost and data quality. Thus, a new DNA sequencing
`approach is required to broaden the applications of genomic
`information in medical research and health care. In this regard,
`DNA sequencing by synthesis (SBS) offers an alternative ap-
`proach to possibly address the limitations of current DNA
`sequencing techniques. We have previously described the design
`of a parallel chip-based SBS system, which uses a self-priming
`DNA template covalently linked to the glass surface of a chip and
`four modified nucleotides (12–14). The nucleotides are modified
`such that they have a photocleavable fluorescent moiety at-
`tached to the base (5 position of pyrimidines, 7 position of
`purines) and a chemically cleavable group to cap the 3⬘-OH.
`When the correct nucleotide is incorporated in a DNA poly-
`merase reaction, specific to the template sequence, the reaction
`is temporarily terminated because of the lack of a free 3⬘-OH
`group. After the fluorescent signal is detected and the nucleotide
`identified, the 3⬘-OH needs to be regenerated to continue
`incorporating the next nucleotide. In the accompanying report,
`
`we have demonstrated that four photocleavable fluorescent
`nucleotides can be efficiently incorporated by DNA polymerase
`into a growing DNA strand base specifically in a polymerase
`extension reaction, and that the fluorophores can be completely
`removed by photocleavage under near-UV irradiation (⬇355
`nm) with high efficiency (15). Using this system in a four-color
`sequencing assay, we were able to accurately identify multiple
`bases in a self-priming DNA template covalently attached to a
`glass surface.
`Another important requirement for this approach to sequence
`DNA unambiguously is a suitable chemical moiety to cap the
`3⬘-OH of the nucleotide such that it terminates the polymerase
`reaction to allow the identification of the incorporated nucleo-
`tide. The capping group then needs to be efficiently removed to
`regenerate the 3⬘-OH, thereby allowing the polymerase reaction
`to continue. Thus, the photocleavable fluorescent nucleotides
`used in SBS must be reversible terminators of the DNA poly-
`merase reaction to allow the detection of the fluorescent signal
`such that the complementary DNA synthesis and sequence
`identification can be efficiently performed in tandem. The
`principal challenge posed by this requirement is the incorpora-
`tion ability of the 3⬘-modified nucleotide by DNA polymerase
`into the growing DNA strand. The 3⬘ position on the sugar ring
`of a nucleotide is very close to the amino acid residues in the
`active site of the DNA polymerase. This is supported by the 3D
`structure of the previously determined ternary complexes of rat
`DNA polymerase, a DNA template-primer, and dideoxycytidine
`triphosphate (16). Thus, any bulky modification at this position
`provides steric hindrance to the DNA polymerase and prevents
`the nucleotide from being incorporated. A second challenge is
`the efficient removal of the capping group once the fluorescence
`signal is detected. Thus, it is important to use a functional group
`small enough to present no hindrance to DNA polymerase,
`stable enough to withstand DNA extension reaction conditions,
`and able to be removed easily and rapidly to regenerate a free
`3⬘-OH under specific conditions.
`Numerous studies have previously been undertaken to identify
`a 3⬘-modified nucleotide as a substrate for DNA polymerase.
`3⬘-O-methyl nucleotides have been shown to be good substrates
`for several polymerases (17). However, the procedure to chem-
`ically cleave the methyl group is stringent and requires anhydrous
`conditions. Thus, it is not practical to use a methyl group to cap
`the 3⬘-OH group for SBS. It has been reported that nucleotides
`with ether linkages at the 3⬘ position can be incorporated by
`some DNA polymerases, whereas those with ester linkages are
`not generally accepted by most of the polymerases tested (18).
`Significant efforts have been dedicated to evaluating a wide
`
`Abbreviations: PC-Bodipy, photocleavable 4,4-difluoro-4-bora-3␣,4␣,4-diaza-s-indacene;
`SBS, sequencing by synthesis; TPPTS, triphenylphosphinetrisulfonate.
`¶To whom correspondence should be addressed at: Russ Berrie Medical Science Pavilion,
`Columbia Genome Center, Room 405A, Columbia University College of Physicians and
`Surgeons, New York, NY 10032. E-mail: ju@genomecenter.columbia.edu.
`
`© 2005 by The National Academy of Sciences of the USA
`
`5932–5937 兩 PNAS 兩 April 26, 2005 兩 vol. 102 兩 no. 17
`
`www.pnas.org兾cgi兾doi兾10.1073兾pnas.0501962102
`
`Downloaded by guest on May 15, 2020
`
`Page 5932
`
`Illumina Ex. 1066
`IPR Petition - USP 10,435,742
`
`

`

`CHEMISTRY
`
`BIOPHYSICS
`
`Scheme 1.
`
`Synthesis of a 3⬘-O-allyl-modified 19-mer oligonucleotide.
`
`oroisopropyl alcohol (pH 8.1). The product was characterized by
`using MALDI-TOF MS.
`
`Deallylation Reaction Performed by Using the 3ⴕ-O-allyl-Modified
`19-mer Oligonucleotide. For the deallylation reaction, we used 55
`eq of Na2PdCl4 and 440 eq of a trisodium triphenylphosphin-
`etrisulfonate (TPPTS) ligand in water at 70°C. Na2PdCl4 in
`degassed water (0.7 ␮l, 2.2 nmol) was added to a solution of
`TPPTS in degassed water (1 ␮l, 17.6 nmol) and mixed well. After
`5 min, a solution of 3⬘-O-allyl-modified oligonucleotide 4 (1 ␮l,
`40 pmol) was added. The reaction mixture was then placed in a
`heating block at 70°C and incubated for 30 sec. The resulting
`deallylated product was desalted by ZipTip (Millipore) and
`analyzed by using MALDI-TOF MS.
`
`Primer Extension Reaction Performed with the Deallylated DNA
`Product. The 10-␮l extension reaction mixture consisted of 45
`pmol of the deallylated DNA product as a primer, 100 pmol of
`a single-stranded synthetic 60-mer DNA template (sequence
`shown in ref. 15) corresponding to a portion of exon 7 of the p53
`gene, 100 pmol of biotin-11–2⬘,3⬘-dideoxyguanosine-5⬘-
`triphosphate (Biotin-11-ddGTP) terminator (PerkinElmer), 1⫻
`Thermo Sequenase reaction buffer, and 4 units of Thermo
`Sequenase DNA polymerase. The extension reaction consisted
`of 15 cycles at 94°C for 20 sec, 48°C for 30 sec, and 60°C for 60
`sec. The product was purified by using solid-phase capture on
`streptavidin-coated magnetic beads (25), desalted by using Zip-
`Tip, and analyzed by using MALDI-TOF MS.
`
`Synthesis of 3ⴕ-O-allyl-dUTP-PC-Bodipy-FL-510. 3⬘-O-allyl-dUTP-
`PC-Bodipy-FL-510 10 was synthesized as shown in Scheme 2.
`Detailed synthesis procedures and characterization data for all
`intermediate compounds (6-9) are described in the supporting
`information.
`PC-Bodipy-FL-510 NHS ester (13) (7.2 mg, 12 mol) in 300 ␮l
`of acetonitrile was added to a solution of 3⬘-O-allyl-5-(3-
`aminoprop-1-ynyl)-2⬘-deoxyuridine-5⬘-triphosphate 9 (2 mg, 4
`mol) in 300 ␮l of Na2CO3-NaHCO3 buffer (0.1 M, pH 8.7). The
`reaction mixture was stirred at room temperature for 3 h. A
`preparative silica-gel TLC plate was used to separate the unre-
`acted PC-Bodipy-FL-510 NHS ester from the fractions contain-
`ing 10 (CHCl3兾CH3OH, 85兾15). The product was concentrated
`further under vacuum and purified with reverse-phase HPLC on
`a 150 ⫻ 4.6-mm C18 column to obtain the pure product 10
`(retention time of 35 min). Mobile phase: A, 8.6 mM triethyl-
`amine兾100 mM hexafluoroisopropyl alcohol in water (pH 8.1);
`B, methanol. Elution was performed with 100% A isocratic over
`10 min, followed by a linear gradient of 0–50% B for 20 min and
`then 50% B isocratic over another 20 min. 3⬘-O-allyl-dUTP-PC-
`
`variety of 3⬘-modified nucleotides to be used as terminators for
`various DNA polymerases and reverse transcriptases, but none
`of the functional groups tested have had established methods to
`regenerate a free 3⬘-OH (19–22).
`It is known that stable chemical functionalities such as allyl
`(OCH2
`OCHACH2) and methoxymethyl (OCH2
`OOOCH3)
`groups can be used to cap an OH group, and can be cleaved
`chemically with high yield (23, 24). We therefore proposed the
`use of such groups as reversible caps for the 3⬘-OH of the
`nucleotide for SBS (12). We report here our efforts in estab-
`lishing the allyl group as a 3⬘-OH capping moiety for the
`nucleotide analogues that can be used in SBS. The choice of this
`group was based on the fact that the allyl moiety, being relatively
`small, would not provide significant hindrance for the polymer-
`ase reaction and would therefore allow the incoming 3⬘-O-allyl-
`modified nucleotide analogue to be accepted by DNA polymer-
`ase. Furthermore, it would be possible to remove this group by
`using catalytic deallylation. Here, we report the design and
`synthesis of a photocleavable fluorescent nucleotide analogue,
`3⬘-O-allyl-dUTP-PC-Bodipy-FL-510 (PC-Bodipy, photocleav-
`able 4,4-difluoro-4-bora-3␣,4␣-diaza-s-indacene), that can be
`efficiently incorporated by DNA polymerase into a growing
`DNA strand. The allyl group can be rapidly and completely
`removed by a Pd-catalyzed reaction to regenerate a 3⬘-OH
`group, and the deallylated DNA can then allow reinitiation of
`the polymerase reaction to incorporate the subsequent nucleo-
`tide analogue.
`
`Materials and Methods
`All chemicals were purchased from Sigma-Aldrich unless oth-
`erwise indicated. Oligonucleotides used as primers or templates
`were synthesized on an Expedite nucleic acid synthesizer (Ap-
`plied Biosystems). 1H NMR spectra were recorded on a Bruker
`400 spectrometer, and 13C and 31P NMR spectra were recorded
`on a Bruker 300 spectrometer. High-resolution MS data were
`obtained by using a JEOL JMS HX 110A mass spectrometer.
`Mass measurement of DNA was made on a Voyager DE
`MALDI-TOF mass spectrometer (Applied Biosystems). Pho-
`tolysis was performed by using a Spectra Physics GCR-150-30
`Nd-yttrium兾aluminum garnet laser that generates light pulses at
`355 nm (⬇50 mJ per pulse; pulse length of ⬇7 ns) at a frequency
`of 30 Hz with a light intensity at ⬇1.5 W兾cm2. Thermo Seque-
`nase DNA polymerase, HIV-1, and RAV2 reverse transcriptases
`were obtained from Amersham Biosciences. Therminator, Vent
`(exo-), Deep Vent (exo-), Bst, and Klenow (exo-) fragment DNA
`polymerases were obtained from New England Biolabs. 9°N
`polymerase (exo-) A485L兾Y409V was generously provided by
`New England Biolabs. Sequenase V2 DNA polymerase, M-
`MulV, and AMV reverse transcriptases were obtained from
`United States Biochemical. Tfl and Tth DNA polymerases were
`obtained from Promega. Pfu (exo-) DNA polymerase was ob-
`tained from Stratagene. Phosphoramidites and columns for
`nucleic acid synthesis were obtained from Glen Research (Ster-
`ling, VA).
`
`Synthesis of a 3ⴕ-O-allyl-Modified 19-mer Oligonucleotide. 3⬘-O-allyl-
`thymidine phosphoramidite 3, prepared according to Scheme 1
`(also see the supporting information, which is published on the
`PNAS web site), was used to synthesize a 19-mer oligonucleotide,
`5⬘-AGA-GGA-TCC-AAC-CGA-GAC-T(allyl)-3⬘ 4 (molecular
`weight of 5,871). The synthesis was carried out in the 5⬘-to-3⬘
`direction by using 3 along with dA-5⬘-CE, dC-5⬘-CE, dG-5⬘-CE,
`and dT-5⬘-CE phosphoramidites and a dA-5⬘-CPG column. The
`oligonucleotide was purified by HPLC, using an Xterra MS C18
`(4.6 ⫻ 50 mm) column (Waters). The elution was performed
`over 90 min at a flow rate of 0.5 ml兾min and a fixed temperature
`of 50°C, using a linear gradient (12–34.5%) of methanol in a
`buffer containing 8.6 mM triethylamine and 100 mM hexaflu-
`
`Ruparel et al.
`
`PNAS 兩 April 26, 2005 兩 vol. 102 兩 no. 17 兩 5933
`
`Downloaded by guest on May 15, 2020
`
`Page 5933
`
`

`

`Scheme 2.
`
`Synthesis of 3⬘-O-allyl-dUTP-PC-Bodipy-FL-510.
`
`Bodipy-FL-510 10 was characterized by the following single-base
`extension reaction and MALDI-TOF MS.
`
`Primer Extension by Using 3ⴕ-O-allyl-dUTP-PC-Bodipy-FL-510 and Pho-
`tocleavage of the Extension Product. An 18-mer oligonucleotide,
`5⬘-AGA-GGA-TCC-AAC-CGA-GAC-3⬘ (molecular weight of
`5,907), was synthesized by using dA-CE, dC-CE, dG-CE, and
`biotin-dT phosphoramidites. A primer extension reaction was
`performed by using a 15-␮l reaction mixture consisting of 50
`pmol of primer, 100 pmol of single-stranded synthetic 60-mer
`DNA template corresponding to a portion of exon 7 of the p53
`gene (15), 200 pmol of 3⬘-O-allyl-dUTP-PC-Bodipy-FL-510, 1⫻
`Thermopol reaction buffer (New England Biolabs), and 15 units
`of 9°N polymerase (exo-) A485L兾Y409V. The extension reaction
`consisted of 15 cycles of 94°C for 20 sec, 48°C for 30 sec, and 60°C
`for 60 sec. A small portion of the DNA extension product 11 was
`desalted by using ZipTip and analyzed by using MALDI-TOF
`MS. The rest of the product was freeze-dried, resuspended in 200
`␮l of deionized water, and irradiated for 10 sec in a quartz cell
`with path lengths of 1.0 cm employing a Nd-yttrium兾aluminum
`garnet laser (⬇355 nm) to cleave the fluorophore from the DNA,
`yielding product 12.
`
`Deallylation of the DNA Extension Product Generated by the Incor-
`poration of 3ⴕ-O-allyl-dUTP-PC-Bodipy-FL-510. The above photo-
`cleaved 3⬘-O-allyl-modified DNA product 12 (180 pmol pro-
`duced in multiple reactions) was dried and resuspended in 1 ␮l
`of deionized H2O. Na2PdCl4 in degassed H2O (4.1 ␮l, 72 nmol)
`was added to a solution of TPPTS in degassed H2O (2.7 ␮l, 9
`nmol) and mixed well. After 5 min, the above DNA product (1
`␮l, 180 pmol) was added. The reaction mixture was then placed
`in a heating block,
`incubated at 70°C for 90 sec to yield
`deallylated product 13, and cooled to room temperature for
`analysis by MALDI-TOF MS.
`
`Polymerase Extension and Photocleavage by Using the Deallylated
`DNA Product as a Primer. The above deallylated DNA product 13
`was used as a primer in a single-base extension reaction. The
`10 ␮l reaction mixture consisted of 50 pmol of the above
`deallylated product 13, 100 pmol of the 60-mer template (15),
`125 pmol of dGTP-PC-Bodipy-FL-510 (14), 4 units of Thermo
`Sequenase DNA polymerase, and 1⫻ reaction buffer. The
`
`extension reaction consisted of 15 cycles of 94°C for 20 sec,
`48°C for 30 sec, and 60°C for 60 sec. The DNA extension
`product 14 was desalted by using the ZipTip protocol, and a
`small portion was analyzed by using MALDI-TOF MS. The
`remaining product was then irradiated with near-UV light for
`10 sec to cleave the fluorophore from the extended DNA
`product. The resulting photocleavage product 15 was desalted
`and analyzed by using MALDI-TOF MS.
`
`Results and Discussion
`In this article, we have shown that an allyl moiety can be
`successfully used as a blocking group for the 3⬘-OH of a
`photocleavable fluorescent nucleotide analogue in SBS to pre-
`vent the DNA polymerase reaction from continuing after the
`incorporation of the 3⬘-O-allyl-modified nucleotide analogue.
`Furthermore, we have demonstrated that the allyl group can be
`efficiently removed to generate a free 3⬘-OH group and allow the
`DNA polymerase reaction to continue to the subsequent cycle.
`Conventional methods for cleavage of the allyl group combine
`a transition metal-catalyzed isomerization of the double bond to
`the enol ether and subsequent hydrolysis of the latter to produce
`the corresponding alcohol (26, 27). For application in SBS, it is
`important to ensure that complete chemical cleavage of the
`3⬘-O-allyl group can be rapidly and specifically carried out while
`leaving the DNA intact. TPPTS has been widely used as a ligand
`for Pd-mediated deallylation under aqueous conditions (28–30),
`whereas an active Pd catalyst can be generated from Na2PdCl4
`and an appropriate ligand (31, 32). Thus, we investigated a
`water-soluble Pd catalyst system generated from Na2PdCl4 and
`TPPTS for deallylation of the 3⬘-O-allyl-modified DNA product.
`To evaluate the cleavage conditions of the allyl group capping
`the 3⬘-OH of DNA, we first synthesized a 19-mer oligonucleotide
`[5⬘-AGAGGATCCAACCGAGAC-T(allyl)-3⬘] using 3⬘-O-allyl-
`thymidine phosphoramidite (Scheme 1). The identity of the
`purified oligonucleotide was established by using MALDI-TOF
`MS. We then tested the above Na2PdCl4兾TPPTS catalyst system
`for the deallylation of the oligonucleotide. In Fig. 1A, the mass
`peak at m兾z 5,871 corresponds to the mass of the purified
`oligonucleotide bearing the allyl group. Fig. 1B shows a single
`mass peak at m兾z 5,831, corresponding to the deallylated DNA
`product, indicating that we were able to achieve near-complete
`deallylation with a DNA兾Na2PdCl4兾TPPTS ratio of 1兾55兾440 in
`
`5934 兩 www.pnas.org兾cgi兾doi兾10.1073兾pnas.0501962102
`
`Ruparel et al.
`
`Downloaded by guest on May 15, 2020
`
`Page 5934
`
`

`

`CHEMISTRY
`
`BIOPHYSICS
`
`indicating that the
`corresponding to the extension product,
`deallylated product can be successfully used as a primer in a
`polymerase reaction.
`The above experiments established that Na2PdCl4 and TPPTS
`could be used to efficiently carry out deallylation on DNA in an
`aqueous environment. Our next step was to investigate whether
`a 3⬘-O-allyl-modified nucleotide could be incorporated in a DNA
`polymerase reaction. For this purpose, we synthesized a nucle-
`otide analogue 3⬘-O-allyl-thymidine triphosphate (3⬘-O-allyl-
`dTTP) (supporting information), which was tested with 15
`different polymerases for incorporation. The tested enzymes
`included Therminator, Thermo Sequenase, Vent (exo-), Deep
`Vent (exo-), Tth, Tfl, Bst, Pfu (exo-), Klenow (exo-) fragment
`and Sequenase DNA polymerases, AMV, RAV2, M-MulV, HIV
`reverse transcriptases, and a 9°N polymerase (exo-) bearing the
`mutations A485L and Y409V. Our preliminary results showed
`that 9°N DNA polymerase (exo-) A485L兾Y409V could effi-
`ciently incorporate 3⬘-O-allyl-dTTP in an extension reaction,
`consistent with results reported recently (31).
`After confirming the incorporation ability of 3⬘-O-allyl-dTTP
`into a growing DNA strand by DNA polymerase, we then
`synthesized a new 3⬘-modified photocleavable fluorescent nu-
`cleotide analogue, 3⬘-O-allyl-dUTP-PC-Bodipy-FL-510, accord-
`ing to Scheme 2, and established that it also can be efficiently
`incorporated by the above polymerase. The aim was to evaluate
`that the presence of the bulky photocleavable fluorescent moiety
`on the base and the allyl group on the 3⬘ end of the nucleotide
`analogue would not affect the polymerase extension reaction.
`Furthermore, we wanted to demonstrate an entire cycle of
`primer extension, photocleavage of the fluorophore, deallylation
`followed by extension with another photocleavable fluorescent
`nucleotide complementary to the next base on the template, and
`photocleavage once again. This experiment will thus test the
`feasibility of using 3⬘-O-allyl-dUTP-PC-Bodipy-FL-510 as a re-
`versible terminator for SBS.
`The entire cycle of a polymerase reaction using 3⬘-O-allyl-
`dUTP-PC-Bodipy-FL-510 as a reversible terminator is depicted
`in Scheme 3. The extension product 11 obtained by using
`3⬘-O-allyl-dUTP-PC-Bodipy-FL-510 and 9°N DNA Polymerase
`(exo-) A485L兾Y409V was purified by using HPLC and analyzed
`by using MALDI-TOF MS. The base in the template immedi-
`ately adjacent to the priming site was ‘‘A.’’ Thus, if 3⬘-O-allyl-
`dUTP-PC-Bodipy-FL-510 was accepted by the polymerase as a
`terminator, the primer would extend by one base and then the
`reaction would terminate. Our results indicate that this was
`indeed the case. After confirming that the extension reaction was
`
`Schematic representation (Left) and step-by-step MALDI-TOF MS
`Fig. 1.
`results (Right) for the deallylation of a 3⬘-O-allyl-modified oligonucleotide
`and the use of the deallylated oligonucleotide as a primer in a polymerase
`extension reaction. (A) Peak at m兾z 5,871 corresponding to the HPLC-purified
`3⬘-O-allyl-modified 19-mer oligonucleotide. (B) Peak at m兾z 5,831 correspond-
`ing to the above oligonucleotide without the allyl group, obtained after 30 sec
`of incubation with Na2PdCl4 and TPPTS [P(PhSO3Na)3] at 70°C. (C) Peak at m兾z
`6,535 corresponding to the extension of the deallylated oligonucleotide by
`Biotin-11-ddGTP using Thermo Sequenase DNA polymerase.
`
`a reaction time of 30 sec. The next step was to prove that the
`above deallylated DNA product could be used as a primer in a
`polymerase extension reaction. We therefore carried out a
`single-base extension reaction using the deallylated DNA prod-
`uct as a primer, a synthetic template, and a biotin-11-ddGTP
`nucleotide terminator that was complementary to the base
`immediately adjacent to the priming site on the template. The
`DNA extension product was isolated by using solid-phase cap-
`ture purification and analyzed by using MALDI-TOF MS (25).
`The mass spectrum in Fig. 1C shows a clear peak at m兾z 6,535
`
`Scheme 3. One entire polymerase reaction cycle using 3⬘-O-allyl-dUTP-PC-Bodipy-FL-510 as a reversible terminator.
`
`Ruparel et al.
`
`PNAS 兩 April 26, 2005 兩 vol. 102 兩 no. 17 兩 5935
`
`Downloaded by guest on May 15, 2020
`
`Page 5935
`
`

`

`successful, we irradiated it with near-UV light at 355 nm for 10
`sec to cleave the fluorophore from the DNA, generating product
`12. In an SBS system, this step would ensure that there would be
`no carryover of the fluorescence signal into the next incorpo-
`ration cycle so as to prevent the generation of ambiguous data
`at each step, as shown in the companion article (15). The
`photocleavage product 12 was then incubated with a Na2PdCl4兾
`TPPTS catalyst system at 70°C for 90 sec to perform deallylation.
`The deallylated DNA product 13 was purified by reverse-phase
`HPLC and then used as a primer in a second DNA extension
`reaction to prove that the regenerated 3⬘-OH was capable of
`allowing the polymerase reaction to continue. For the extension
`reaction, we used a photocleavable fluorescent nucleotide
`dGTP-PC-Bodipy-FL-510 and Thermo Sequenase DNA poly-
`merase. The extension product 14 was irradiated as above for 10
`sec to generate photocleavage product 15 and hence complete an
`entire reversible termination cycle.
`After each step in the above cycle, a portion of the product was
`purified and analyzed by using MALDI-TOF MS to confirm its
`identity and the successful completion of that step. Each product
`was desalted by using the ZipTip desalting protocol to ensure the
`generation of sharp and well resolved data free from salt peaks.
`The MALDI-TOF MS data for the product in each step are
`shown in Fig. 2. Fig. 2 A shows the primer extension product 11
`at m兾z 6,787 generated by using 3⬘-O-allyl-dUTP-PC-Bodipy-
`FL-510. The peak at m兾z 6,292 corresponds to the photocleavage
`product that was generated by the partial photocleavage of the
`extension product due to the nitrogen laser (⬇337 nm) used for
`ionization of the analyte in MALDI-TOF MS. Fig. 2B shows the
`photocleavage result after the 10-sec irradiation of the extension
`product at 355 nm. It can be seen from the data that the peak
`at m兾z 6,787, corresponding to the extension product, has
`completely vanished, and only a single peak corresponding to 12
`remains at m兾z 6,292, which proves that photocleavage was
`efficiently achieved. Fig. 2C shows a similar single peak at m兾z
`6,252, which corresponds to the deallylated photocleavage prod-
`uct 13. The absence of a significant peak at m兾z 6,292 proves that
`deallylation was completed with high efficiency. Fig. 2D shows
`the MALDI-TOF MS data for the extension product obtained
`by using the above deallylated DNA product 13 as a primer and
`nucleotide analogue dGTP-PC-Bodipy-FL-510. A dominant
`peak is seen at m兾z 7,133 corresponding to the extension product
`14. Finally, Fig. 2E shows a clear peak at m兾z 6,637 correspond-
`ing to the photocleavage product 15 and no significant peak at
`m兾z 7,133, indicating that complete photocleavage had occurred.
`The results of the above experiments provide sufficient proof of
`the feasibility of using the allyl group as a reversible capping moiety
`for the 3⬘-OH of the photocleavable nucleotide analogues for SBS,
`validating the approach we had previously proposed (12). We have
`shown that a 3⬘-O-allyl-modified nucleotide bearing a photocleav-
`able fluorophore is an excellent substrate for 9°N DNA polymerase
`A485L兾Y409V and can be incorporated with high efficiency in a
`polymerase extension reaction. We have also demonstrated that
`complete photocleavage is achieved in ⬇10 sec on these DNA
`products. Furthermore, we have shown that deallylation can be
`swiftly achieved to near completion under mild reaction conditions
`in an aqueous environment by using a palladium catalyst. Finally,
`we have established that the deallylated DNA product can be used
`as a primer to continue the polymerase reaction and that extension
`and photocleavage can be performed with high efficiency. These
`findings confirm that an allyl moiety protecting the 3⬘-OH group
`indeed bestows the capability of reversible terminating abilities to
`photocleavable nucleotide analogues, which can be used for SBS to
`facilitate the development of this approach for high-throughput
`DNA sequencing and genotyping.
`
`We thank New England Biolabs for generously providing the 9°N DNA
`polymerase (exo-) A485L兾Y409V. This work was supported by National
`
`Fig. 2. MALDI-TOF MS results for each step of a polymerase reaction cycle
`using 3⬘-O-allyl-dUTP-PC-Bodipy-FL-510 as a reversible terminator. (A) Peak at
`m兾z 6,787 corresponding to the primer extension product 11 obtained by
`using 3⬘-O-allyl-dUTP-PC-Bodipy-FL-510 and the 9°N polymerase (exo-) A485L兾
`Y409V. (B) Peak at m兾z 6,292 corresponding to the photocleavage product 12.
`(C) Peak at m兾z 6,252 corresponding to the photocleavage product without
`the allyl group 13 obtained after 90 sec of incubation with the catalyst and
`ligand at 70°C. (D) Peak at m兾z 7,133 corresponding to the extension product
`14 from the purified deallylated product using dGTP-PC-Bodipy-FL-510 and
`Thermo Sequenase DNA polymerase. (E) Peak at m兾z 6,637 corresponding to
`the photocleavage product 15.
`
`Institutes of Health Center of Excellence in Genomic Science Grants P50
`HG002806 and R01 HG003582 and the Packard Fellowship for Science
`and Engineering.
`
`5936 兩 www.pnas.org兾cgi兾doi兾10.1073兾pnas.0501962102
`
`Ruparel et al.
`
`Downloaded by guest on May 15, 2020
`
`Page 5936
`
`

`

`CHEMISTRY
`
`BIOPHYSICS
`
`1. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J.,
`Devon, K., Dewar, K., Doyle, M., FitzHugh, W., et al. (2001) Nature 409, 860–921.
`2. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G.,
`Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) Science 291,
`1304 -1351.
`3. Roses, A. D. (2000) Nature 405, 857–865.
`4. Collins, F. S., Green, E. D., Guttmacher, A. E. & Guyer, M. S. (2003) Nature
`422, 835–847.
`5. Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D.,
`Rowell, S. E. & King, M. C. (1994) Nat. Genet. 8, 399–404.
`6. Stickney, H. L., Schmutz, J., Woods, I. G., Holtzer, C. C., Dickson, M. C., Kelly,
`P. D., Myers, R. M. & Talbot, W. S. (2002) Genome Res. 12, 1929–1934.
`7. Smith, L. M., Sanders, J. Z., Kaiser, R. J., Hughes, P., Dodd, C., Connell, C. R.,
`Heiner, C., Kent, S. B. H. & Hood, L. E. (1986) Nature 321, 674–679.
`8. Ju, J., Ruan, C., Fuller, C. W., Glazer, A. N. & Mathies, R. A. (1995) Proc. Natl.
`Acad. Sci. USA 92, 4347–4351.
`9. Ju, J., Glazer, A. N. & Mathies, R. A. (1996) Nucleic Acids Res. 24, 1144–1148.
`10. Kan, C. W., Fredlake, C. P., Doherty, E. A. S. & Barron, A. E. (2004)
`Electrophoresis 25, 3564–3588.
`11. Kheterpal, I., Scherer, J., Clark, S. M., Radhakrishnan, A., Ju, J., Ginther, C. L.,
`Sensabaugh, G. F. & Mathies, R. A. (1996) Electrophoresis 17, 1852–1859.
`12. Ju, J., Li, Z., Edwards, J. & Itagaki, Y. (2003) U.S. Patent 6,664,079.
`13. Li, Z., Bai, X., Ruparel, H., Kim, S., Turro, N. J. & Ju, J. (2003) Proc. Natl.
`Acad. Sci. USA 100, 414–419.
`14. Seo, T. S., Bai, X., Ruparel, H., Li, Z., Turro, N. J. & Ju, J. (2004) Proc. Natl.
`Acad. Sci. USA 101, 5488–5493.
`15. Seo, T. S., Bai, X., Kim, D. H., Meng, Q., Shi, S., Ruparel, H., Li, Z., Turro,
`N. J. & Ju, J. (2005) Proc. Natl. Acad. Sci. USA 102, 5926–5931.
`16. Pelletier, H., Sawaya, M. R., Kumar, A., Wilson, S. H. & Kraut, J. (1994)
`Science 264, 1891–1903.
`
`17. Axelrod, V. D., Vartikyan, R. M., Aivazashvili, V. A. & Beabealashvili, R. S.
`(1978) Nucleic Acids Res. 5, 3549–3563.
`18. Metzker, M. L., Raghavachari, R., Richards, S., Jacutin, S. E., Civitello, A.,
`Burgess, K. & Gibbs, R. A. (1994) Nucleic Acids Res. 22, 4259–4267.
`19. Beabealashvili, R. S., Scamrov, A. V., Kutateladze, T. V., Mazo, A. M.,
`Krayevsky, A. A. & Kukhanova, M. K. (1986) Biochim. Biophys. Acta 868,
`136–144.
`20. Kutateladze, T. V., Kritzyn, A. M., Florentjev, V. L., Kavsan, V. M., Chidgeav-
`adze, Z. G. & Beabealashvili, R. S. (1986) FEBS Lett. 207, 205–212.
`21. Chidgeavadze, Z. G. & Beabealashvili, R. S. (1984) Nucleic Acids Res. 12,
`1671–1686.
`22. Canard, B., Cardona, B. & Sarfati, R. S. (1995) Proc. Natl. Acad. Sci. USA 21,
`10859–10863.
`23. Guibe, F. (1998) Tetrahedron 54, 2967–3042.
`24. Sabitha, G., Babu, R. S., Rajkumar, M., Srividya, R. & Yadav, J. S. (2001) Org.
`Lett. 3, 1149–1151.
`25. Edwards, J. R., Itagaki, Y. & Ju, J. (2001) Nucleic Acids Res. 29, e104.
`26. Karakawa, M., Kamitakahara, H., Takano, T. & Nakatsubo, F. (2002) Biomac-
`romolecules 3, 538–546.
`27. Honda, M., Morita, H. & Nagakura, I. (1997) J. Org. Chem. 62, 8932–
`8936.
`28. Lacroix, T., Bricout, H., Tilloy, S. & Monflier, E. (1999) Eur. J. Org. Chem. 11,
`3127–3129.
`29. Lemaire, S., Savignac, M., Blart, E. & Bernard, J. M. (1997) Tetrahedron Lett.
`38, 2955–2958.
`30. Genet, J. P., Blart, E. & Savignac, M. (1994) Tetrahedron 50, 497–503.
`31. Milton, J., Wu, X., Smith, M., Brennan, J., Barnes, C., Liu, X. & Ruediger, S.
`(2004) PCT Intl. Patent Appl. WO 0418497.
`32. DeVasher, R. B., Moore, L. R. & Shaughnessy, K. H. (2004) J. Org. Chem. 69,
`7919–7927.
`
`Ruparel et al.
`
`PNAS 兩 April 26, 2005 兩 vol. 102 兩 no. 17 兩 5937
`
`Downloaded by guest on May 15, 2020
`
`Page 5937
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket